Bluejay Diagnostics (BJDX) Other Accumulated Expenses (2020 - 2026)

Bluejay Diagnostics' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $104829.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 0.61% year-over-year to $104829.0; the TTM figure through Mar 2026 stood at $104829.0 (up 0.61% YoY), while the FY2025 annual figure was $156567.0, up 35.58% from the prior year.
• Other Accumulated Expenses came in at $104829.0 for Q1 2026 at Bluejay Diagnostics, down from $156567.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $231635.0 in Q3 2024 to a low of $104194.0 in Q1 2025.
• A 4-year average of $154209.1 and a median of $156567.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses slipped 25.29% in 2024 and jumped 35.58% in 2025, its largest moves.
• Bluejay Diagnostics' Other Accumulated Expenses stood at $154575.0 in 2023, then retreated by 25.29% to $115479.0 in 2024, then soared by 35.58% to $156567.0 in 2025, then sank by 33.05% to $104829.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $104829.0, $156567.0, and $189088.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison